Research News and Research

RSS

QuadraMed announces the launch of its ICD-10 Countdown Program

QuadraMed® Corporation, a leading provider of healthcare information technologies and services that help turn quality care into positive financial outcomes, today announced the launch of its ICD-10 Countdown Program. This new program includes the Quantim® ICD-10 Coding Simulator software, ICD-10 educational tools and services to guide healthcare providers through the ICD-10 conversion.

5 Oct 2009

Biochemics signs research collaboration agreement with Unilever

BioChemics, Inc. a company “enhancing drug delivery through biophysical modulation,” is pleased to announce the signing of a research collaboration agreement with Unilever, one of the world’s largest consumer goods companies, to utilize BioChemics’ proprietary topical delivery technology for the delivery of Unilever’s compounds.

5 Oct 2009

Pharmacogenomics Centre deploys the Isilon IQ to accelerate its next-generation genetic sequencing operations

Isilon® Systems (Nasdaq: ISLN), the proven leader in scale-out NAS, today announced that Pharmacogenomics Centre, a partnership between Genome Quebec and the Montreal Heart Institute focused on enhancing new and existing drug development research programs through the inclusion of genetic information, has deployed Isilon IQ to accelerate its next-generation genetic sequencing operations.

5 Oct 2009

Sigma-Aldrich and Sangamo Biosciences extend license agreement for ZFP technology

Sigma-Aldrich Corporation and Sangamo BioSciences, Inc. (Nasdaq: SGMO) today announced a major expansion of their existing license agreement to include the exclusive rights to develop and distribute zinc finger DNA binding protein (ZFP)-modified cell lines for commercial production of protein pharmaceuticals.

5 Oct 2009

New technique for tracing ultra-fine particles

Limit values for fine dust emissions are based on total particle weight. It is the ultra-fine particles, however, that are particularly harmful to health. A new technique separates them by size and identifies their composition - directly where they arise.

5 Oct 2009

Jefferies expands its global Healthcare Investment Banking Group

Jefferies today announced the expansion of its global Healthcare Investment Banking Group with the hiring of five senior professionals. Henry Elphick, Tommy Erdei and Probir Rao join as Managing Directors, Gil Bar-Nahum as a Senior Vice President, and Andrew Clayton as a Vice President. Henry Elphick, Tommy Erdei and Gil Bar-Nahum are based in London, Probir Rao is based in Mumbai, and Andrew Clayton in Hong Kong.

5 Oct 2009

Positive results from Depomed's Phase 3 clinical trial of DM-1796 for postherpetic neuralgia

Depomed, Inc. today announced top-line results from a Phase 3 clinical trial demonstrating DM-1796 (also referred to as gabapentin ER) achieved a statistically significant reduction in pain associated with postherpetic neuralgia (PHN) versus placebo using the baseline observation carried forward (BOCF) method required by FDA.

5 Oct 2009

Theraclone and Zenyaku Kogyo sign multi-year research and development agreement

Theraclone Sciences, Inc., a Seattle-based biotechnology company, and Zenyaku Kogyo Co., Ltd., a pharmaceutical company based in Tokyo, today announced that they have entered into a multi-year research and development agreement.

5 Oct 2009

First edition: October 5, 2009

The continuing efforts to make progress on the nation's health overhaul are reflected in today's headlines, which highlight both politics and policies.

5 Oct 2009

NOAA awards $457,000 grant to track and manage outbreaks of toxic red tide algae

NOAA has awarded $457,000 in competitive grant funding to support three projects to better track and manage outbreaks of toxic red tide algae that threaten public health and New England's shellfish industry. The grant covers the first year of what will be multi-year projects. Anticipated to cost almost $1.5 million over the next three years, they will be carried out by the Woods Hole Oceanographic Institution, the University of Maine and the University of Texas.

5 Oct 2009

Survey finds majority of Americans are at risk of heart disease due to their lifestyle factor

To help draw attention to National Child Health Day (today), the Preventive Cardiovascular Nurses Association (PCNA) has released findings from a new national consumer survey and launched a campaign to educate families about heart disease, the leading cause of death in the U.S.

5 Oct 2009

GVK Biosciences and Quantitative Solutions to develop and market clinical trial outcome databases

GVK Biosciences (GVK BIO), Asia’s leading integrated research services provider and Quantitative Solutions (QS), a modeling and simulation (M&S) consultancy to the pharmaceutical and biotech industry, announced a strategic partnership to develop and market clinical trial outcome databases.

5 Oct 2009

Genentech is again the world's most respected biopharmaceutical employer

Science annual survey of Top Employers polls employees in the biotechnology, biopharmaceutical, pharmaceutical, and related industries. Respondents to the web-based survey are asked to rate companies based on 23 driving characteristics, including financial strength, easy adaptation to change, and a research-driven environment.

5 Oct 2009

Prompt diagnosis and treatment for otitis media benefits organ transplant recipients

Organ transplant recipients benefit significantly when they are monitored and receive prompt diagnosis and treatment for otitis media, a common inner ear infection.

5 Oct 2009

Autistic patients have underlying medical disorders that are amenable to treatment

The National Children's Health Survey published results from a 2007 telephone survey in Pediatrics today in which 78,000 households in the US were asked if their child (ages 2-17) was known to "currently have autism, Asperger's Disorder, pervasive development disorder, or other autism spectrum disorder." The survey showed that 1% of children (one in 100) now have the disorder. Previous estimates from the CDC had reported a prevalence rate of one in 150.

5 Oct 2009

Oral Cancer Foundation initiates program to donate VELscope screening systems

The Oral Cancer Foundation recently initiated a program of donating VELscope® Oral Cancer Screening Systems to free clinics and others located in, and helping communities with, underserved populations.

5 Oct 2009

Willow Breast Cancer Support Canada calls for national Metastatic Breast Cancer Awareness Day

Thousands of Canadian women with metastatic breast cancer and their loved ones are marking the first Canadian Metastatic Breast Cancer Awareness Day on October 13, urging Canadians to acknowledge them and delivering the message that "hope changes."

5 Oct 2009

Research confirms that probiotic bacteria promotes health and boosts immune system

Functional food is the food industry's fastest-growing product group, its leading products including dairy products which contain probiotics, that is, bacteria promoting health. Valio's Lactobacillus rhamnosus GG (LGG®) is the most frequently studied and used probiotic.

5 Oct 2009

Inovio's SynCon H1N1 achieves protective antibody response against pandemic influenza in ferrets

Inovio Biomedical Corporation, a leader in DNA vaccine design, development and delivery, announced today that a combination of its synthetic consensus (SynConTM) H1N1 influenza vaccine candidates achieved protective antibody responses against the novel pandemic influenza A/H1N1 (2009) in 100% of tested ferrets.

5 Oct 2009

Research study on facial esthetics

Standard ideals of facial beauty and harmony may differ depending on geographic location, with a specific difference between North American beauty ideals and those of Brazilians.

5 Oct 2009

Research News and Research

QuadraMed announces the launch of its ICD-10 Countdown Program

Biochemics signs research collaboration agreement with Unilever

Pharmacogenomics Centre deploys the Isilon IQ to accelerate its next-generation genetic sequencing operations

Sigma-Aldrich and Sangamo Biosciences extend license agreement for ZFP technology

New technique for tracing ultra-fine particles

Jefferies expands its global Healthcare Investment Banking Group

Positive results from Depomed's Phase 3 clinical trial of DM-1796 for postherpetic neuralgia

Theraclone and Zenyaku Kogyo sign multi-year research and development agreement

First edition: October 5, 2009

NOAA awards $457,000 grant to track and manage outbreaks of toxic red tide algae

Survey finds majority of Americans are at risk of heart disease due to their lifestyle factor

GVK Biosciences and Quantitative Solutions to develop and market clinical trial outcome databases

Genentech is again the world's most respected biopharmaceutical employer

Prompt diagnosis and treatment for otitis media benefits organ transplant recipients

Autistic patients have underlying medical disorders that are amenable to treatment

Oral Cancer Foundation initiates program to donate VELscope screening systems

Willow Breast Cancer Support Canada calls for national Metastatic Breast Cancer Awareness Day

Research confirms that probiotic bacteria promotes health and boosts immune system

Inovio's SynCon H1N1 achieves protective antibody response against pandemic influenza in ferrets

Research study on facial esthetics

Human iPSCs: A Full Guide to Advanced in Vitro Models and Applications eBook

Latest eBooks

Editorial Focus eBook - Spatial and single-cell omics (1st edition)

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Industry Focus eBook - Cell biology (5th edition)

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics